Relating to disease control programs to reduce the risk of certain communicable diseases.
Impact
The legislation amends the Health and Safety Code by adding a new subchapter that specifically outlines the operations and regulations surrounding disease control programs. Notably, the bill permits local health authorities to charge a fee for needle and syringe exchanges, which must not exceed 150% of the actual cost, thus introducing a potential revenue source for public health initiatives. Additionally, it mandates that program operators report on the effectiveness of their initiatives, thereby ensuring accountability and transparency in the handling of public funds and health strategies.
Summary
House Bill 272 addresses the establishment of disease control programs aimed at reducing the risk of certain communicable diseases, particularly HIV, hepatitis B, and hepatitis C. The bill allows local health authorities or contracted organizations to set up programs that include the anonymous exchange of used hypodermic needles and syringes for new ones, health education in multiple languages, and assistance in accessing health-related services. The legislation is intended to improve public health outcomes through preventive measures against the spread of infectious diseases.
Contention
There are significant implications related to public safety and health concerns surrounding the implementation of these programs. Proponents argue that needle exchange programs can effectively reduce the transmission rates of communicable diseases and provide crucial healthcare services to high-risk populations. However, opponents may challenge the affordability of participation fees, the safety of such exchanges, and the potential for increased drug use in communities. As with similar measures, discussions around appropriate funding sources and community education efforts will be vital to successful implementation.
Relating to the establishment by certain counties and hospital districts of disease control pilot programs to reduce the risk of certain infectious and communicable diseases; authorizing fees.
Relating to infection prevention and control programs and other measures for communicable diseases at certain long-term care facilities; authorizing an administrative penalty.
Relating to judicial review of certain orders issued to address a declared state of disaster, declared public health disaster, or ordered public health emergency or to prevent the spread of a communicable disease.
Relating to repealing certain offenses and removing certain regulations relating to the cultivation, manufacture, delivery, and possession of marihuana and cannabis.
Requires pharmacies to sell hypodermic syringes and needles to any customer over the age of 18 and post sign concerning consumer right to purchase clean syringes and needles.
Requires pharmacies to sell hypodermic syringes and needles to any customer over the age of 18 and post sign concerning consumer right to purchase clean syringes and needles.
Requires pharmacies to sell hypodermic syringes and needles to any customer over the age of 18 and post sign concerning consumer right to purchase clean syringes and needles.